Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by Revolution Medicines, Inc. on June 16, 2022. The filing details the voting results for four proposals presented to stockholders of record as of April 21, 2022, when 74,232,891 shares of common stock were outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and stockholder voting outcomes rather than financial performance.
Material Changes and Voting Results
Stockholders voted on four proposals with the following outcomes:
- Proposal 1 (Election of Directors): Stockholders elected three Class II directors (Sushil Patel, Eric T. Schmidt, and Thilo Schroeder) to serve until the 2025 annual meeting. All nominees received majority support, though Eric T. Schmidt and Thilo Schroeder received significant votes withheld (approximately 12% and 12.5% respectively).
- Proposal 2 (Ratification of Auditors): Stockholders ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022, with overwhelming support (99.9% for).
- Proposal 3 (Say-on-Pay): Stockholders approved, on an advisory basis, the compensation of named executive officers. Approximately 92% of votes cast were in favor.
- Proposal 4 (Say-on-Pay Frequency): Stockholders approved holding future advisory votes on executive compensation on an annual basis. Approximately 93% of votes cast supported the one-year frequency option.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on business strategy, risks, contingencies, or unusual items. The document is limited to the tabulation of votes and the determination that future executive compensation advisory votes will occur annually.
Key Facts for Investor Verification
- Verify the specific reasons for the higher-than-average votes withheld for directors Eric T. Schmidt and Thilo Schroeder compared to Sushil Patel.
- Confirm the total number of shares outstanding (74,232,891) against the sum of votes cast, withheld, and broker non-votes to ensure accuracy in the tabulation.
- Note that the company has committed to annual "say-on-pay" votes based on the stockholder preference expressed in Proposal 4.
- Review the definitive proxy statement (Schedule 14A filed April 26, 2022) for detailed biographies of the elected directors and the full compensation discussion referenced in Proposal 3.